文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

机器人脾切除术的患者选择、实践模式与围术期结局:基于ACS-NSQIP的当代分析

Patient selection, practice patterns, and perioperative outcomes for robotic splenectomy: a contemporary ACS-NSQIP analysis.
PubMed 文献 · Surg Endosc · 2026-06-09

基于ACS-NSQIP数据库2022至2023年852例脾切除术患者,机器人脾切除占19%,腹腔镜39.7%,开腹41.1%。机器人组最常见指征为良性血液病(33%)、肿瘤/肿块/囊肿(32%)和脾肿大(18%)。与腹腔镜相比,机器人手术时间更长(152 vs 130 min,p<0.001)但住院更短(3.6 vs 5.2天,p=0.010),中转开腹、输血及其他并发症无显著差异。

要点

  • 机器人脾切除占脾切除的19%,最常见指征为良性血液病、肿瘤/囊肿和脾肿大。
  • 与腹腔镜相比,机器人手术时间更长但住院更短,中转开腹和并发症无差异。
  • 机器人脾切除安全、并发症低,需合理选择患者。

核心结论

  • 在大样本当代全国队列中,机器人脾切除安全、并发症低,与腹腔镜相比住院更短但手术时间更长。

研究设计与样本

  • 回顾性队列研究,查询ACS-NSQIP数据库2022至2023年成人脾切除患者,按手术方式分组比较围术期结局。
  • 共852例 eligible 患者,机器人163例(19%),腹腔镜339例(39.7%),开腹350例(41.1%)。

主要发现

  • 机器人脾切除最常见指征为良性血液病(33%)、肿瘤/肿块/囊肿(32%)和脾肿大(18%)。
  • 机器人组手术时间152 min,腹腔镜组130 min,差异显著(p<0.001)。
  • 机器人组住院时间3.6天,腹腔镜组5.2天,差异显著(p=0.010)。
  • 两组中转开腹比例、术后输血及其他术后并发症无显著差异。

临床怎么用

  • 机器人脾切除可作为安全术式,在合理选择患者的前提下考虑使用。
  • 需权衡机器人手术时间较长与住院时间较短的特点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted surgery has increasingly been adopted across multiple surgical specialties, demonstrating benefits such as enhanced precision and visualization, and potentially improved outcomes. However, evidence for its use in less common operations, including splenectomy, remains limited. To better understand its use and outcomes, we examined practice patterns and perioperative results of robotic splenectomy in a large, contemporary national cohort. METHODS: The American College of Surgeons - National Surgical Quality Improvement Program database was queried for adult patients who underwent open, laparoscopic, or robotic splenectomy from 2022 to 2023; patient characteristics were categorized by type of surgical approach. Perioperative outcomes for robotic vs. laparoscopic splenectomy were analyzed using univariable and multivariable analyses. RESULTS: Among 852 eligible patients that underwent splenectomy, 163 (19%) operations were performed using the robotic approach, while 339 (39.7%) were laparoscopic and 350 (41.1%) were open. The most common indications for robotic splenectomy were benign hematologic conditions (33%), neoplasm/mass/cyst (32%), and splenomegaly (18%). Compared to laparoscopic surgery, robotic splenectomy was associated with longer operative time (152 vs. 130 min, p < 0.001) but shorter length of stay (3.6 vs. 5.2 days, p = 0.010). Notably, there were no significant differences in the proportion of patients experiencing an unplanned conversion to open surgery, postoperative blood transfusions, or other postoperative complications between the robotic and laparoscopic cohorts. CONCLUSION: In this large contemporary national cohort, robotic splenectomy was safe, with low morbidity, shorter hospitalization, and longer operative times compared to laparoscopic surgery. These findings support the feasibility and safety of robotic splenectomy with appropriate patient selection.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Farooq MS, Jona A, Vargas GM, et al. Patient selection, practice patterns, and perioperative outcomes for robotic splenectomy: a contemporary ACS-NSQIP analysis. Surg Endosc. 2026. PMID: 42265293. doi:10.1007/s00464-026-12964-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。